Neural mechanism of rebooting the unconsciousness caused by midazolam

LeYuan Gu,WeiHui Shao,Lu Liu,Qing Xu,YuLing Wang,JiaXuan Gu,Yue Yang,ZhuoYue Zhang,YaXuan Wu,Yue Shen,Qian Yu,XiTing Lian,Haixiang Ma,YuanLi Zhang,HongHai Zhang
DOI: https://doi.org/10.1101/2023.03.20.533578
2024-03-12
Abstract:The advent of midazolam has significant implications for modern clinical practice. The hypnotic and sedative effects of midazolam give it a wide range of clinical utility. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain unknown. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, we revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus (VLPO) noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) is a mechanistically important binding site in the LC for midazolam. Our findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.
Neuroscience
What problem does this paper attempt to address?
The paper primarily explores the neural mechanisms of midazolam-induced changes in consciousness and attempts to identify effective intervention targets to promote the recovery of consciousness. Specifically, the study addresses the following key issues: 1. **Role of the LC-VLPO Pathway**: The research reveals the role of the noradrenergic neural circuit from the locus coeruleus (LC) to the ventrolateral preoptic nucleus (VLPO) in regulating midazolam-induced changes in consciousness. This effect is mainly mediated through α1-adrenergic receptors. 2. **Role of GABAA Receptors**: The study finds that GABAA receptors in the LC are an important binding site for midazolam. Midazolam inhibits the central nervous system by enhancing the action of GABA. 3. **Intervention Strategy**: The research proposes a possible intervention strategy, which is to promote recovery from midazolam-induced loss of consciousness by activating the LC-VLPO noradrenergic neural circuit. This may help guide the timing of clinical medication and suggest effective intervention targets. In summary, the paper aims to understand how midazolam affects the state of consciousness and to explore methods that can promote rapid recovery of consciousness in patients. This is of great significance for reducing the side effects of midazolam use and improving patient outcomes.